ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 261

Impact of Rheumatoid Arthritis on Outcomes of Atrial Fibrillation: Results for National Inpatient Sample

Shraddha Jatwani1, Karan Chugh 1, Bikramjit Bindra 2 and Karan Jatwani 3, 1St. Vincent Evansville, Evansville, 2Government Medical College & Hospital, Chandigarh, India, 3Mount Sinai West - St Luke’s Hospital, New York

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Cardiovascular disease, health outcome and comorbidity, Rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Health Services Research Poster I – ACR/ARP

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Atrial Fibrillation (AF) is a common cardiac arrhythmia related to increased cardiovascular morbidity and mortality. There is a significant association of systemic inflammation with the pathogenesis of AF. Several studies have assessed the relationship of AF with Rheumatoid Arthritis (RA) with variable results. Some studies suggest 29-40% higher incidence of AF with RA, while others did not find any increased risk of AF in RA. In this study, we used the National Inpatient Sample (NIS) to assess the impact of RA on demographics, mortality, length of stay, and cost per hospitalization for AF in comparison to non-RA hospitalizations.

Methods: Healthcare Cost and Utilization Project’s NIS is the largest all-payer inpatient database in the United States with discharge data from >1200 hospitals, located across the nation. We queried the National Inpatient Sample from 2010-2014 to identify adult hospitalizations for AF with and without RA, using validated ICD-9 CM codes. Logistic regression analysis was used to identify independent associations with in-hospital mortality. Multivariate regression was applied to adjust for confounders.

Results: There were an estimated 43910 adult hospitalizations for AF with a secondary diagnosis of RA, from 2010 to 2014. On univariate analysis, the average age for hospitalizations with AF in the non-RA group was 70.03years, whereas, in the RA group, the average age for was 73.26 years (p< 0.001). 72.15% of all hospitalizations with AF & RA were females (significantly higher, p-value < 0.001). Unadjusted logistic regression suggested an increased risk of mortality in patients with AF & RA with an odds ratio of 1.297 (p value=0.01), but after adjusting for confounders, a relative decrease in mortality was identified patients with AF & RA (Adjusted Odds Ratio=0.781; p value=0.025). Unadjusted Linear regression for length of stay (LOS) per hospitalization suggested longer length of stay for patients with AMI & RA (3.837 days vs. 3.41 days, p-value < 0.001), but when adjusted for confounders with multivariate regression, LOS was found to be lower (Coefficient = -0.243; p value< 0.001)

Conclusion: This study reports contemporary data of AF & RA hospitalizations over five years in the United States. It suggests that patients with AF and RA have similar and possibly better outcomes for mortality compared to the non-RA population when adjusted for confounding factors like age, gender, and other demographic factors. Further prospective studies are needed to understand the relationship between AF and RA.


AF RA Table 1

Table 1: Baseline Demographics of hospitalizations for Atrial Fibrillation -AF- without and with underlying Rheumatoid Arthritis -RA-


Disclosure: S. Jatwani, None; K. Chugh, None; B. Bindra, None; K. Jatwani, None.

To cite this abstract in AMA style:

Jatwani S, Chugh K, Bindra B, Jatwani K. Impact of Rheumatoid Arthritis on Outcomes of Atrial Fibrillation: Results for National Inpatient Sample [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/impact-of-rheumatoid-arthritis-on-outcomes-of-atrial-fibrillation-results-for-national-inpatient-sample/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-rheumatoid-arthritis-on-outcomes-of-atrial-fibrillation-results-for-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology